Results 141 to 150 of about 223,475 (293)

Long‐term prognosis of pure and impure tachycardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Background and aims Tachycardia‐induced cardiomyopathy (TCM) is a reversible form of heart failure (HF) driven by arrhythmias, often atrial fibrillation (AF). While reversible, TCM's long‐term prognosis remains unclear, especially in comparison to HF with reduced ejection fraction (HFrEF).
Giulia Stronati, Michele Alfieri, Niki Tombolesi, Alessandro Barbarossa, Samuele Principi, Federico Gullì, Arianna Massari, Gianmarco Bastianoni, Francesca Roccetti, Michela Casella, Antonio Dello Russo, Federico Guerra   +11 more
wiley   +1 more source

A new method of myocardial revascularization by laser

, 1987
Masayoshi Okada, Hiroshi Ikuta, Kazuta Shimizu, Hiroyuki Horii, Kazuo Nakamura   +4 more
openalex   +2 more sources

The Y graft: Myocardial revascularization with both internal thoracic arteries [PDF]

, 1994
Sidney Chocron, Joseph-Philippe Etievent, François Schiele, C. François, Kifah Alwan, A. Cordier, N Schipman, Jean-Louis Mourand   +7 more
openalex   +1 more source

Early and late outcomes of single versus bilateral internal thoracic artery revascularization for patients in critical condition

, 2021
Michal Fertouk, Amit Gordon, Dmitry Pevni, Tomer Ziv‐Baran, Orr Sela, Rephael Mohr, Ariel Farkash, Amir Kramer, Nadav Teich, Nachum Nesher, Yanai Ben‐Gal   +10 more
openalex   +2 more sources

Prognostic impact of SCAI shock severity classes in AMI‐related cardiogenic shock: A sub‐study of the ECLS‐SHOCK Trial

ESC Heart Failure, EarlyView.
Patients with AMI‐CS (lactate >3 mmol/L) enrolled in the multicentre, randomized ECLS‐SHOCK trial were included. From a total of 417 patients, 51.6% (n = 215), 13.4% (n = 56) and 35.0% (n = 146) presented in SCAI Stages C, D and E, respectively. SCAI stages were associated with the risk of 30 day all‐cause mortality, with rates of renal replacement ...
Janine Pöss, Jacob Jentzer, Steffen Desch, Hans‐Josef Feistritzer, Anne Freund, Michelle Roßberg, Christian Jung, Taoufik Ouarrak, Steffen Schneider, Ibrahim Akin, Tienush Rassaf, Tharusan Thevathasan, Uwe Zeymer, Holger Thiele   +13 more
wiley   +1 more source

Impact of standardized team‐based care on cardiogenic shock outcomes over time

ESC Heart Failure, EarlyView.
This contemporary North American cardiogenic shock (CS) registry aimed to investigate the influence of team‐based care on outcomes over a six‐year period of time following implementation of standardized protocols. Despite a two‐fold increase in the number of CS patients and changes in presentation and management strategies, no differences in in ...
Behnam N. Tehrani, Carolyn M. Rosner, Adetokunbo Fadahunsi, Kimberly Barker, Wayne B. Batchelor, Vanessa Blumer, Lindsay Clevenger, Shashank Desai, Michelle Ferri, Evan Franke, Jamie Kennedy, Christopher King, Edward Howard, Iyad Isseh, Seiyon Ben Lee, Aditya Mehta, Mitchell Psotka, Ramesh Singh, Shashank S. Sinha, Matthew W. Sherwood, Daniel Tang, Megan Terek, Alexander G. Truesdell, Ilan Vavilin, Christopher M. O'Connor   +24 more
wiley   +1 more source

Giant isolated profunda femoris artery aneurysm treated with aneurysmal ligation without profunda femoris artery revascularization

, 2023
Naveed A. Rahman, Zachary E. Williams, Asad Choudhry, Scott M. Surowiec   +3 more
openalex   +1 more source

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

New England Journal of Medicine, 2002
M. Morice, P. Serruys, J. Sousa, J. Fajadet, E.Ban Hayashi, M. Perin, A. Colombo, G. Schuler, P. Barragan, G. Guagliumi, F. Molnár, R. Falotico   +11 more
semanticscholar   +1 more source

Minimization or withdrawal of oral pharmacotherapy in chronic heart failure patients with improved myocardial function: A systematic review

European Journal of Heart Failure, EarlyView.
This systematic review included seven studies that reported the outcomes of minimization or withdrawal of oral pharmacotherapy in chronic heart failure (HF) patients with improved myocardial function. There is a dearth of existing evidence, which supports only loop diuretic withdrawal and possibly carvedilol monotherapy.
Yuxiang Luo, Wenbin Xiao, Yusuf Z. Sener, Wouter C. Meijers, Robert M.A. van der Boon, Elfatih A. Hasabo, Osama Soliman, Rudolf A. de Boer, Kadir Caliskan   +8 more
wiley   +1 more source

Albuminuria as a diagnostic criterion and a therapeutic target in heart failure and other cardiovascular disease

European Journal of Heart Failure, EarlyView.
The value of uACR. CKD, chronic kidney disease; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; uACR, urine albumin‐to‐creatinine ratio. Abstract The high disease burden and bidirectional relationship of chronic kidney disease (CKD), heart failure (HF) and other cardiovascular disease (CVD) necessitate the need for early ...
Biykem Bozkurt, Patrick Rossignol, Joseph A. Vassalotti   +2 more
wiley   +1 more source